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Nonsyndromic hearing loss is one of the most genetically heterogeneous traits known. A total of 30 autosomal
dominant nonsyndromic hearing–loss loci have been mapped, and 11 genes have been isolated. In the majority of
cases, autosomal dominant nonsyndromic hearing loss is postlingual and progressive, with the exception of hearing
impairment in families in which the impairment is linked to DFNA3, DFNA8/12, and DFNA24, the novel locus
described in this report. DFNA24 was identified in a large Swiss German kindred with a history of autosomal
dominant hearing loss that dates back to the middle of the 19th century. The hearing-impaired individuals in this
kindred have prelingual, nonprogressive, bilateral sensorineural hearing loss affecting mainly mid and high fre-
quencies. The DFNA24 locus maps to 4q35-qter. A maximum multipoint LOD score of 11.6 was obtained at
208.1 cM at marker D4S1652. The 3.0-unit support interval for the map position of this locus ranges from 205.8
cM to 211.7 cM (5.9 cM).
Hearing loss is a common form of sensory impairment
that affects millions of individuals worldwide (Wilson
1985). Of the hereditary forms of hearing loss, ∼70%
of the cases are nonsyndromic in nature—that is, hearing
loss is the only clinical feature (Morton 1991). Nonsyn-
dromic hearing loss is one of the most genetically het-
erogeneous traits known (Van Camp et al. 1997). More
than 60 loci have been mapped, and a total of 15 genes
have been identified (Hereditary Hearing Loss Home-
page). The extreme genetic heterogeneity of nonsyn-
dromic hearing loss suggests that there are many differ-
ent processes that can malfunction within the inner ear
to cause hearing loss (Heller and Hudspeth 1998). Be-
cause of the extreme genetic heterogeneity of nonsyn-
dromic hearing loss, an important strategy in mapping
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novel loci has been to use individual kindreds that can
independently establish linkage.
Thus far, for autosomal dominant nonsyndromic
hearing loss, a total of 30 loci have been mapped and
11 genes have been isolated (Hereditary Hearing Loss
Homepage). In the majority of cases, autosomal domi-
nant nonsyndromic hearing loss is postlingual and pro-
gressive, with the exception of hearing impairment in
families in which the hearing loss is linked to DFNA3
(MIM 601544), DFNA8/12 (MIM 601543/601842),
and DFNA24, the novel locus described here. For
DFNA3, hearing impairment is due to mutations in one
of two genes, GJB2 (MIM 121011) or GJB6 (MIM
604418). Mutations within the TECTA gene (MIM
602574) are responsible for hearing impairment due to
DFNA8/12.
The Swiss German kindred (102) presented here has
a history of bilateral prelingual nonprogressive senso-
rineural hearing loss that dates back to the middle of
the 19th century. Kindred 102 (fig. 1) was ascertained
through the Department of Otolaryngology at the Uni-
versity Hospital of Zurich. Informed consent was ob-
tained from all study participants and from the parents
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Figure 2 Genetic map location of linked markers on chromo-
some 4, delineating the DFNA24 locus. Map distances from the
Marshfield map are given in centimorgans. Bold markers were gen-
otyped for the genome scan. The disease interval, determined on the
basis of recombination events, is flanked by markers GATA129D03
and UT1366/D4S1523 (7.88 cM).
of minor study participants. A family history was ob-
tained through an oral interview. Audiometric and DNA
samples were obtained from pedigree members in three
generations.
Blood samples were collected from 47 pedigree mem-
bers, and a buccal swab was collected from one family
member aged !6 years. Of the study subjects from whom
DNA samples were obtained, 26 individuals were hear-
ing impaired because of the DFNA24 locus, 16 had nor-
mal hearing, and 7 were the spouses of hearing-impaired
pedigree members.
Auditory thresholds were determined by standard
pure-tone audiometry with air conduction at 125–8,000
Hz and bone conduction at 250–4,000 Hz. In addition,
where possible, previous audiologic tests were collected.
Audiograms for the 26 hearing-impaired family mem-
bers displayed mild to profound hearing loss, mainly in
the frequencies between 0.5 KHz and 4 KHz. The hear-
ing-impaired family members all had sloping audio-
grams affecting mainly the mid to high frequencies.
Hearing-impaired individuals with severe to profound
hearing loss in the high frequencies also had moderate
hearing loss in the mid and low frequencies. The hearing
loss appears to be nonprogressive, with no correlation
between severity of hearing loss and current age. No
evidence of acquired risk factors predisposing to hearing
loss was observed for the hearing-impaired family
members.
On the basis of medical history, there was no evidence
that the hearing loss in this kindred is part of a syn-
drome. It is of interest to note that facioscapulohumeral
(FSH) muscular dystrophy (FSHMD1A [MIM 158900]),
which maps to the same region as DFNA24, is associated
with early-onset sensorineural hearing loss. The family
members of kindred 102 do not present with muscle
weakness, ruling out FSHMD1A as a diagnosis.
DNA was extracted from 10 ml of blood by means
of standard techniques (Miller et al. 1988). A genome
scan was performed on 46 DNA samples at the National
Heart, Lung, and Blood Institute (NHLBI [NIH]) mam-
malian genotyping service, using the Marshfield Screen-
ing set 9 (Yuan et al. 1997). A total of 386 fluorescently
labeled simple tandem-repeat (STRP) markers with an
average heterozygosity of 0.76 were genotyped. These
markers are spaced ∼10 cM apart and are located on
the 22 autosomes and the X and Y chromosomes.
Linkage analysis was performed under a fully pene-
trant autosomal dominant mode of inheritance with no
phenocopies. A disease frequency of .001 was used in
the analysis. The marker allele frequencies were esti-
mated from the data by means of both observed and
reconstructed genotypes of founders within the pedi-
grees. We performed two-point linkage analysis on all
autosomal markers from the genome scan, using
MLINK of the FASTLINK computer package (Cot-
tingham et al. 1993). A maximum two-point LOD score
of 4.9 with marker D4S1652 was obtained. D4S1652
was the most telomeric chromosome 4 marker included
in the genome scan. No other marker gave a LOD score
13. Flanking distal markers to D4S1652, D4S408, and
D4S241 produced maximum LOD scores of 2.03 and
0.71, respectively. Multipoint linkage analysis with
LINKMAP of the FASTLINK computer package ruled
out that the DFNA24 locus lies between D4S408 and
D4S241 (data not shown).
For fine mapping, five additional markers were
selected from the Marshfield map (Broman et al.
1998); four of these markers—D4S3047, D4S171,
GATA129D03, D4S426—lie between D4S408 and
D4S1652, and one additional marker—D4S1523—is
1440 Am. J. Hum. Genet. 66:1437–1442, 2000
Table 1
Two-Point LOD Score Results between the DFNA24 Locus and Chromosome 4
Markers
MARKER
LOD SCORE AT v =
.0 .01 .05 .10 .20 .30 .40
D4S408 /AFM165xc1  2.66 .35 1.25 1.50 1.12 .55
D4S3047 /AFMa071yh9  1.39 1.58 2.40 2.45 1.79 .88
D4S171 /Mfd22  .60 2.80 3.29 3.02 2.18 1.11
GATA129D03  6.02 6.21 5.83 4.62 3.16 1.55
D4S426 /AFM238ve3 6.63 6.52 6.04 5.42 4.11 2.73 1.34
D4S1652 /GATA5B02 4.86 4.75 4.34 3.81 2.73 1.67 .74
D4S1523 /UT1366  8.57 8.52 7.85 6.11 4.11 1.98
Figure 3 Results from the multipoint linkage analysis. A maximum multipoint LOD score of 11.6 occurred at marker D4S1652 at 208.1
cM. The 7.9-cM interval to which DFNA24 maps is flanked by recombination events at markers GATA129D03 and UT1366/D4S1523.
telomeric to D4S1652 (fig. 2). No other markers were
available from this region that would allow for finer
mapping of the DFNA24 locus. Forty-eight DNA sam-
ples were genotyped for these markers: the DNA samples
included in the genome scan, plus two additional DNA
samples, sample V.23, which was ascertained after the
initial genome scan was carried out, and sample VI.15,
for which only a limited amount of DNA was available,
since a buccal swab had been collected. The data were
reanalyzed by means of two-point and multipoint link-
age analyses. The results of the two-point linkage anal-
ysis are displayed in table 1. A maximum two-point
LOD score of 8.57 was obtained at recombination frac-
tion (v) .01 for marker D4S1523, which is the most
telomeric marker on chromosome 4. A graph of the re-
sults of the multipoint analysis is displayed in figure 3.
A maximum multipoint LOD score of 11.6 occurred at
marker D4S1652 at 208.1 cM, with a 3.0-unit support
interval from 205.08 cM to 211.7 cM (5.9 cM).
SIMWALK2 (Weeks et al. 1995) was used to generate
the haplotypes with the highest likelihood (fig. 1). The
interval to which DFNA24 maps is flanked by recom-
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bination events at marker GATA129D03 and UT1366/
D4S1523. The interval between these two markers is
7.9 cM.
In the region 4q35-qter, there are two known ex-
pressed sequence tags (ESTs) that are expressed in the
cochlea, SHGC-33691 and SHGC-35919 (Human
Cochlear cDNA Library and EST Database). Genes and
ESTs expressed in the cochlea are potential candidates
for DFNA24, because all known mutations leading to
deafness in humans occur in genes that are expressed in
the specialized cell types of the cochlea.
The EST SHGC-35919 belongs to the unigene cluster
Hs.16506. The ESTs within this cluster are widely ex-
pressed (i.e., colon, heart, kidney, lung, and stomach).
The EST SHGC-33691 (unigene Hs.9817) is within the
ArgBP2 gene (Wang et al. 1997). ArgBP2 is widely ex-
pressed in human tissue and is associated with the actin
cytoskeleton. ArgBP2 is a potential candidate gene for
DFNA24, because another widely expressed actin-as-
sociated protein, the human homologue of Drosophila
melanogaster diaphanous (DIAPH1 [MIM 602121]), is
responsible for nonsyndromic hearing loss due to
DFNA1 (MIM 124900).
Relatively few genes have been identified within the
interval where DFNA24 is localized. Current knowledge
of genes other than ArgBP2 within this region does not
suggest they are potential candidates for DFNA24.
These genes include adenine nucleotide translocator 1
(ANT1 [MIM 103220]), coagulation factor XI (F11
[MIM 264900]), homologue of Drosophila FAT tumor
suppressor (FAT [MIM 600976], interferon regulatory
factor 2 (IRF2 [MIM 147576]), melatonin receptor 1A
(MTNR1A [MIM 600665]), and toll-like receptor 3
(TLR3 [MIM 603029]).
It is also of interest to note that FSH muscular dys-
trophy (MIM 158900) maps to this region. A number
of FSH muscular dystrophy cases with early-onset bi-
lateral high-frequency sensorineural hearing loss have
been reported (Small 1968; Taylor et al. 1982; Padberg
et al. 1992). In some cases, the hearing loss was pro-
gressive and, over time, also involved lower frequencies
(Voit et al. 1986). These findings make the FSH muscular
dystrophy region gene 1 (FRG1 [MIM 601278]), once
identified, a potential candidate for DFNA24.
In several cases, different mutations within the same
gene are responsible for both syndromic and nonsyn-
dromic forms of hearing loss. For example, the myosin
VIIA gene (MYO7A [MIM 276903]) is responsible for
Usher syndrome type 1B (USH1B [MIM 276903]),
DFNB2 (MIM 600060), and DFNA11 (MIM 601317).
The pendrin gene (PDS [MIM 274600]) is responsible
for Pendred syndrome (MIM 274600) and DFNB14
(MIM 603678). Mutations in the COL11A2 gene (MIM
120290) cause otospondylomegaepiphyseal dysplasia
(OSMED [MIM 215150]), Weissenbacher-Zwymuller
syndrome (WZS [MIM 277610]), Stickler syndrome
nonocular type (STL2 [MIM 184840]), and DFNA13
(MIM 601868). Linkage of the DFNA24 locus to 4q35-
qter is an essential first step in gene identification that
will provide insight into the pathophysiology of this
disorder.
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